| Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept S Rojekar, LF Abadi, R Pai, K Mahajan, S Kulkarni, PR Vavia European Journal of Pharmaceutical Sciences 164, 105916, 2021 | 21 | 2021 |
| Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy S Rojekar, R Pai, LF Abadi, K Mahajan, MK Prajapati, S Kulkarni, P Vavia International Journal of Pharmaceutics 607, 120986, 2021 | 20 | 2021 |
| In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)–PEG–Doxorubicin for Targeted Cancer Therapy S Pawar, K Mahajan, P Vavia AAPS PharmSciTech 18, 3021-3033, 2017 | 11 | 2017 |
| Layer-by-layer assembled nanostructured lipid carriers for CD-44 receptor–based targeting in HIV-infected macrophages for efficient HIV-1 inhibition K Mahajan, S Rojekar, D Desai, S Kulkarni, G Bapat, S Zinjarde, P Vavia AAPS PharmSciTech 22 (5), 171, 2021 | 7 | 2021 |
| Efavirenz loaded nanostructured lipid carriers for efficient and prolonged viral inhibition in HIV-infected macrophages K Mahajan, S Rojekar, D Desai, S Kulkarni, P Vavia Pharmaceutical Sciences 27 (3), 418-432, 2020 | 6 | 2020 |
